Integrated BioPharma, Inc. (INBP)

OTCMKTS · Delayed Price · Currency is USD

0.2800

+0.0100 (3.70%)

Apr 1, 2026, 9:30 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
Contract Manufacturing	51.68M	48.57M	48.28M	54.09M	61.84M
Contract Manufacturing Growth	6.41%	0.60%	-10.75%	-12.52%	20.48%
Other Nutraceutical Businesses	2.67M	1.75M	2.40M	2.16M	1.72M
Other Nutraceutical Businesses Growth	52.72%	-26.97%	11.14%	25.00%	19.47%
Total	54.35M	50.32M	50.67M	56.25M	63.56M
Total Growth	8.02%	-0.70%	-9.91%	-11.51%	20.45%

Revenue by Geography

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017	Jun '16 Jun 30, 2016
United States	43.63M	42.34M	42.62M	46.52M	54.39M
United States Growth	3.03%	-0.64%	-8.38%	-14.47%	22.78%
International	10.73M	7.97M	8.06M	9.73M	9.17M
International Growth	34.53%	-1.02%	-17.21%	6.07%	8.25%
Total	54.35M	50.32M	50.67M	56.25M	63.56M
Total Growth	8.02%	-0.70%	-9.91%	-11.51%	20.45%

Source: S&P Global Market Intelligence.